Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

The Avicenna Alliance co-organises a public workshop at the FDA on good simulation practices in health technologies

The Avicenna Alliance, the Medical Device Innovation Consortium (MDIC) and the...

find out more ›

The Avicenna Alliance nominated as a member of the European Commission's "eHealth Stakeholder Group"

On 3 February, Thierry Marchal, Secretary-General of the Avicenna Alliance has been informed that...

find out more ›

Avicenna Alliance puts forward questions to EU Expert Panel on effective ways of investing in health

On 17 December the European Commission launched a survey inviting stakeholders to put forward...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up